Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine to prevent catheter-related bladder discomfort after gynecologic laparoscopy
ChiCTR2500102866Phase 4Not yet recruiting
- Sponsor
- Shenzhen Maternal and Child Health Hospital
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine in cystitis (2 arms), sponsored by Shenzhen Maternal and Child Health Hospital. Primary endpoint: Incidence of catheter-related bladder discomfort (CRBD). Planned start May 2025; status: not yet recruiting.
02
Drugs
nalbuphine
03
Conditions
cystitis
Beyond the preview
Go deeper on ChiCTR2500102866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102866.